Condition
Tricuspid Regurgitation (TR) clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Tricuspid Regurgitation (TR) clinical trials that are recruiting, at sites in 10 countries (most in United States (4), Germany (2), Italy (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 10Countries
Newest Tricuspid Regurgitation (TR) clinical trials
All recruiting trials (10)
-
What happens to the tricuspid valve in atrial fibrillation patients without strong valve leakage
This study looks at how the tricuspid valve changes over a year in people with atrial fibrillation who don’t have significant valve leakage, using 3D heart imaging.
-
Early rhythm control in atrial fibrillation with tricuspid regurgitation
This study tests whether starting rhythm control early in people with atrial fibrillation and tricuspid regurgitation can improve outcomes compared with usual care.
-
TriClip System post-market safety and performance in real-world tricuspid regurgitation patients
This study tests whether the TriClip System is safe and works well for adults with tricuspid regurgitation in routine care settings.
-
Topaz TTVR vs EVOQUE TTVR for severe tricuspid regurgitation
A study tests whether the TRiCares Topaz transcatheter tricuspid valve replacement system works safely and effectively for adults with severe tricuspid regurgitation who are candidates for valve replacement.
-
Robotic transjugular tricuspid valve replacement using the Lux-valve plus system.
This trial tests a robotic transjugular procedure using the Lux-valve plus to replace the tricuspid valve in adults with severe symptomatic tricuspid regurgitation who are high risk for open surgery.
-
LuX-Valve Plus vs EVOQUE for transvenous tricuspid replacement in severe tricuspid regurgitation
This trial tests whether the LuX-Valve Plus system can safely and effectively treat adults with severe tricuspid regurgitation compared to the EVOQUE device.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
Transcatheter tricuspid annular repair for severe symptomatic functional tricuspid regurgitation
This study will try a transcatheter annular therapy device in adults with severe, symptomatic functional tricuspid regurgitation to see if it is safe and can be placed successfully.
-
Treatment for severe tricuspid regurgitation using the Pivot Extend device
This study is testing a new device to see if it can help people with severe tricuspid regurgitation who haven't improved with regular treatments.
-
Pacemaker implantation after tricuspid valve replacement
This study is testing how to best manage pacemaker implantation in patients who have had a transcatheter tricuspid valve replacement to improve their care and outcomes.
Related topics
Quick answers
How many Tricuspid Regurgitation (TR) clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (4 trials), Germany (2 trials), Italy (2 trials), Paraguay (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.